Explaining the Importance of Molecular Testing to Patients With NSCLC
Presented by
Sponsored by
The Academy of Oncology Nurse & Patient Navigators (AONN+) is pleased to introduce an educational video in which expert nurse navigators and nurse practitioners discuss how to explain the importance of molecular testing to patients with resectable or metastatic non-small cell lung cancer in a way that patients and caregivers can understand.
This video is part 3 of a 5-part educational video series we’ve produced in partnership with AstraZeneca. Topics of discussion in this video include:
- How do you explain the importance of molecular testing to patients?
- What are some of the challenges you see with molecular testing and how are you overcoming them?
- How does your institution handle molecular testing in resectable non-small cell lung cancer?
- How do you handle molecular testing in metastatic non-small cell lung cancer?
- What do you most want community nurse navigators and nurse practitioners to know about molecular testing for patients with resectable and metastatic non-small cell lung cancer?